name: Osteogenesis Imperfecta Type I
creation_date: '2026-02-06T03:25:37Z'
updated_date: '2026-02-17T21:53:14Z'
category: Mendelian
description: >
  Osteogenesis imperfecta type I (OI type I) is the mildest form of osteogenesis
  imperfecta, caused by heterozygous null mutations in COL1A1 leading to quantitative
  deficiency of type I collagen (haploinsufficiency). Affected individuals have
  blue sclerae, mild bone fragility with variable fracture frequency, near-normal
  stature, and may develop hearing loss in adulthood. Unlike the more severe OI
  types caused by structural collagen mutations, type I results from reduced
  collagen quantity rather than abnormal collagen structure.
disease_term:
  preferred_term: Osteogenesis imperfecta type I
  term:
    id: MONDO:0008146
    label: osteogenesis imperfecta type 1
parents:
- Osteogenesis imperfecta
inheritance:
- name: Autosomal Dominant
  description: >
    Autosomal dominant inheritance with high penetrance but variable expressivity.
    Most cases are inherited from an affected parent; de novo mutations also occur.
pathophysiology:
- name: Type I Collagen Haploinsufficiency
  description: >
    Null mutations in COL1A1 (nonsense, frameshift, splice site mutations causing
    nonsense-mediated mRNA decay) result in ~50% reduction in type I collagen
    production. The collagen that is produced has normal structure, explaining
    the milder phenotype compared to dominant-negative structural mutations.
  cell_types:
  - preferred_term: Osteoblast
    term:
      id: CL:0000062
      label: osteoblast
  biological_processes:
  - preferred_term: Collagen Fibril Organization
    term:
      id: GO:0030199
      label: collagen fibril organization
  - preferred_term: Bone Development
    term:
      id: GO:0060348
      label: bone development
  evidence:
  - reference: PMID:1353940
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Dermal fibroblasts from most individuals with osteogenesis imperfecta (OI) type
      I produce about half the normal amount of type I procollagen, as a result of
      decreased synthesis of one of its constituent chains, pro alpha 1 (I).
    explanation: >-
      Landmark paper demonstrating that OI type I results from 50% reduced type I
      procollagen synthesis due to diminished pro alpha 1(I) chain production.
  - reference: PMID:23529829
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      COL1A1 haploinsufficiency mutations lead to the mildest form of osteogenesis
      imperfecta (OI), OI type I.
    explanation: >-
      Large clinical study (86 patients) confirming that COL1A1 haploinsufficiency
      specifically causes the mild type I phenotype.
genetic:
- name: COL1A1 Null Mutations
  association: Causative
  notes: >
    Heterozygous null mutations in COL1A1 account for most OI type I cases.
    These include nonsense mutations, frameshift mutations, and splice site
    mutations that lead to nonsense-mediated decay of the mutant transcript.
    The 50% reduction in collagen quantity produces a milder phenotype than
    structural mutations.
  evidence:
  - reference: PMID:1353940
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In each case there was marked diminution in steady-state mRNA levels from one
      COL1A1 allele. Loss of an allele through deletion or rearrangement was not the
      cause of the diminished COL1A1 mRNA levels.
    explanation: >-
      Study of 23 individuals from 21 families showed null allele-associated mRNA
      reduction, establishing the molecular basis of COL1A1 haploinsufficiency.
  - reference: PMID:9443882
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Analysis of the COL1A1 and COL1A2 genes by PCR amplification and scanning by
      conformation-sensitive gel electrophoresis identifies only COL1A1 mutations
      in
      15 patients with osteogenesis imperfecta type I.
    explanation: >-
      Demonstrates that OI type I is specifically associated with COL1A1 mutations,
      with common null-allele mutation sequences identified.
phenotypes:
- name: Blue Sclerae
  description: >
    Blue or blue-gray scleral hue is characteristic and persists into adulthood,
    distinguishing type I from type IV OI where sclerae normalize with age.
  phenotype_term:
    preferred_term: Blue sclerae
    term:
      id: HP:0000592
      label: Blue sclerae
- name: Recurrent Fractures
  description: >
    Increased bone fragility leads to fractures, often with minimal trauma.
    Fracture frequency is variable and typically decreases after puberty.
  phenotype_term:
    preferred_term: Recurrent fractures
    term:
      id: HP:0002757
      label: Recurrent fractures
  evidence:
  - reference: PMID:23529829
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The average rate of long-bone fracture (femur, tibia/fibula, humerus, radius/ulna)
      in pediatric patients was 0.62 fractures per year, one-half of which affected
      the
      tibia/fibula. Long-bone fracture rate was negatively associated with age.
    explanation: >-
      Quantifies fracture rate in COL1A1 haploinsufficiency patients and confirms
      that fracture frequency decreases with age.
- name: Near-Normal Stature
  description: >
    Height is typically in the low-normal range, distinguishing type I from
    the more severe forms with significant short stature.
  phenotype_term:
    preferred_term: Normal stature
    term:
      id: HP:0000002
      label: Abnormality of body height
  frequency: EXCLUDED
  evidence:
  - reference: PMID:23529829
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The average final height Z-score was -1.1, representing a deficit of 8 to 10
      cm
      compared to the general population.
    explanation: >-
      Documents that OI type I patients have only mild height reduction (Z-score -1.1),
      confirming near-normal stature compared to severe OI types.
- name: Hearing Impairment
  description: >
    Progressive hearing loss develops in approximately 50% of adults with OI
    type I, typically beginning in the second or third decade.
  phenotype_term:
    preferred_term: Hearing impairment
    term:
      id: HP:0000365
      label: Hearing impairment
- name: Joint Hypermobility
  description: >
    Generalized joint hypermobility due to connective tissue laxity.
  phenotype_term:
    preferred_term: Joint hypermobility
    term:
      id: HP:0001382
      label: Joint hypermobility
- name: Easy Bruising
  description: >
    Increased tendency to bruise due to connective tissue fragility.
  phenotype_term:
    preferred_term: Easy bruisability
    term:
      id: HP:0000978
      label: Bruising susceptibility
treatments:
- name: Bisphosphonate Therapy
  description: >
    Bisphosphonates (pamidronate, zoledronic acid) are used to increase bone
    mineral density and reduce fracture frequency, particularly in children.
  treatment_term:
    preferred_term: Bisphosphonate therapy
    term:
      id: MAXO:0000954
      label: bisphosphonate agent therapy
- name: Physical Therapy
  description: >
    Exercise and physical therapy to strengthen muscles and improve mobility
    while protecting fragile bones.
  treatment_term:
    preferred_term: Physical therapy
    term:
      id: MAXO:0000011
      label: physical therapy
- name: Fracture Management
  description: >
    Standard orthopedic management of fractures with appropriate immobilization.
  treatment_term:
    preferred_term: Orthopedic surgery
    term:
      id: MAXO:0000004
      label: surgical procedure
datasets:
references:
- reference: DOI:10.1007/s00223-024-01266-5
  title: Update on the Genetics of Osteogenesis Imperfecta
  findings: []
- reference: DOI:10.1210/endrev/bnab017
  title: 'Osteogenesis Imperfecta: Mechanisms and Signaling Pathways Connecting Classical
    and Rare OI Types'
  findings: []
- reference: DOI:10.1371/journal.pone.0309801
  title: Pleiotropic effects of a recessive Col1a2 mutation occurring in a mouse
    model of severe osteogenesis imperfecta
  findings: []
- reference: DOI:10.3390/jcm13123484
  title: 'Unraveling the Link of Altered TGFÎ² Signaling with Scoliotic Vertebral Malformations
    in Osteogenesis Imperfecta: A Comprehensive Review'
  findings: []
